Myriad CDx Test Approved to Guide Ovarian Cancer Therapy
SALT LAKE CITY, March 17, 2026 Myriad Genetics, Inc. announced that the U.S. Food and Drug Administration (FDA) has...
Genomic Testing
Advertisement
mdxhealth Showcases GPS Test Advancing Prostate Care
Irvine, California, March 16, 2026 mdxhealth SA announced new clinical data from the ProMPT study led by the University...
Retevmo Shows Strong Survival Benefit in RET+ Lung Cancer
INDIANAPOLIS, Feb. 16, 2026 — Eli Lilly and Company announced positive Phase III results demonstrating that Retevmo® (selpercatinib) delivered...
Oncology NGS Market Accelerates as Precision Medicine Grows
Boston, MA – December 2025 – The global Clinical Oncology Next-Generation Sequencing (NGS) market is expanding rapidly as cancer...
GeneseeqPrime Gains FDA 510(k) Clearance for Tumor Profiling Kit
TORONTO, Sept. 2, 2025 – Geneseeq Technology Inc. announced that its GeneseeqPrime® NGS Tumor Profiling Assay has received 510(k)...
Advertisement
